Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1)

Details 詳細情報について

• CRID

  1361981470685817216

• DOI

  10.1016/j.rmed.2017.03.025

• ISSN

  09546111

• Web Site

  https://api.elsevier.com/content/article/PII:S0954611117300975?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0954611117300975?httpAccept=text/plain

• Data Source

  • Crossref